Search results for "Highlights"


 
Results 171 - 180 of about 376 for "Highlights".

Highlights

The intervention for Medicare beneficiaries with prediabetes includes at least 16 weekly hour-long sessions over months 1 to 6 and at least 6 monthly maintenance sessions over months 6 to 12.
November 2016

Highlights

These results clearly highlight the need to respect existing recommendations for dose reduction of sulphonylureas when initiating treatment with DPP-4 inhibitors, and the urgency to determine the efficacy of this
May 2016

Highlights

The blood glucose awareness training involved three 2.5-hour group sessions over 4 weeks plus 2 online modules to be done between group meetings.
November 2016

Highlights

Non-endocrinologist clinicians who electronically ordered glargine at a dose of 0.5 units/kg or greater incurred a warning screen, which advised either lowering the dose or contacting the diabetes consult service for approval.
September 2016

Highlights

Elevations in high-sensitivity troponin T or N-terminal pro-B-type natriuretic peptide were significantly associated with risk of cardiovascular death, myocardial infarction, and hospitalization for heart failure, while C-reactive protein was a less
October 2016

Highlights

The intensive intervention was initially conducted for a median of 7.8 years and used both pharmacologic and behavioral methods to target coexisting risk factors for late complications of diabetes.
September 2016

Highlights

The findings of this study should provide some reassurance to patients treated with incretin-based drugs, according to the authors.
August 2016

Highlights

Patients with type 2 diabetes and a systolic blood pressure of 110 to 119 mm Hg appeared to have a lower risk of cardiovascular disease than patients who had systolic blood pressures of 130 to 139 mm Hg, according to a registry study.
August 2016

Highlights

The study looked at data from the Sweden National Diabetes Register to determine what patient characteristics were related to all-cause mortality or death from cardiovascular-, diabetes-, or cancer-related causes.
July 2016

Highlights

The U.K.-based retrospective cohort study used a database that linked national hospitalization and mortality data for people who were prescribed second-line regimens after metformin.
July 2016

Result Page: Prev   13   14   15   16   17   18   19   20   21   22   Next